These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25732572)

  • 1. Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients.
    Yin JY; Meng XG; Qian CY; Li XP; Chen J; Zheng Y; Liu R; Zhou HH; Liu ZQ
    Acta Pharmacol Sin; 2015 Mar; 36(3):375-84. PubMed ID: 25732572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients.
    Yin JY; Li X; Li XP; Xiao L; Zheng W; Chen J; Mao CX; Fang C; Cui JJ; Guo CX; Zhang W; Gao Y; Zhang CF; Chen ZH; Zhou H; Zhou HH; Liu ZQ
    Cancer Lett; 2016 Jul; 377(1):65-73. PubMed ID: 27126360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population.
    Wu W; Zhang W; Qiao R; Chen D; Wang H; Wang Y; Zhang S; Gao G; Gu A; Shen J; Qian J; Fan W; Jin L; Han B; Lu D
    Clin Cancer Res; 2009 Jun; 15(11):3889-95. PubMed ID: 19458053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer.
    Zheng D; Chen Y; Gao C; Wei Y; Cao G; Lu N; Hou Y; Jiang X; Wang J
    Cancer Biol Ther; 2014; 15(11):1542-51. PubMed ID: 25482940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.
    Qian J; Qu HQ; Yang L; Yin M; Wang Q; Gu S; Wu Q; Zhao X; Wu W; Wu J; Tan X; Chen W; Wang H; Wang J; Fan W; Chen H; Han B; Lu D; Wei Q; Jin L
    Oncologist; 2012; 17(12):1551-61. PubMed ID: 22843554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.
    Wu W; Li H; Wang H; Zhao X; Gao Z; Qiao R; Zhang W; Qian J; Wang J; Chen H; Wei Q; Han B; Lu D
    PLoS One; 2012; 7(3):e33200. PubMed ID: 22479369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients.
    Cai W; Chen C; Li X; Shi J; Sun Q; Liu D; Sun Y; Hou L; Zhao X; Gu S; Wu Q; Chen H; Zhang W; Jin L; Lu D; Fei K; Su B; Qian J
    Future Oncol; 2014 May; 10(7):1175-85. PubMed ID: 24947259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
    Tan X; Wu Q; Cai Y; Zhao X; Wang S; Gao Z; Yang Y; Li X; Qian J; Wang J; Su B; Chen H; Han B; Jiang G; Lu D
    Clin Lung Cancer; 2014 Jan; 15(1):67-78.e12. PubMed ID: 24220096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VCP gene variation predicts outcome of advanced non-small-cell lung cancer platinum-based chemotherapy.
    Peng J; Yang LX; Zhao XY; Gao ZQ; Yang J; Wu WT; Wang HJ; Wang JC; Qian J; Chen HY; Jin L; Bai CX; Han BH; Wang WM; Lu DR
    Tumour Biol; 2013 Apr; 34(2):953-61. PubMed ID: 23412975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC.
    Qian J; Liu H; Gu S; Wu Q; Zhao X; Wu W; Wang H; Wang J; Chen H; Zhang W; Wei Q; Jin L; Lu D
    Clin Lung Cancer; 2015 Sep; 16(5):e37-53. PubMed ID: 25818095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients.
    Powrózek T; Mlak R; Krawczyk P; Homa I; Ciesielka M; Kozioł P; Prendecka M; Milanowski J; Małecka-Massalska T
    Clin Transl Oncol; 2016 Feb; 18(2):125-31. PubMed ID: 26193985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer.
    Jia M; Zhu M; Wang M; Sun M; Qian J; Ding F; Chang J; Wei Q
    Oncotarget; 2016 May; 7(18):25291-303. PubMed ID: 26993769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients.
    Xu X; Han L; Yang H; Duan L; Zhou B; Zhao Y; Qu J; Ma R; Zhou H; Liu Z
    Lung Cancer; 2013 Jan; 79(1):65-72. PubMed ID: 23127338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
    Qian CY; Zheng Y; Wang Y; Chen J; Liu JY; Zhou HH; Yin JY; Liu ZQ
    Chin J Cancer; 2016 Sep; 35(1):85. PubMed ID: 27590272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter methylation of hOGG1 may be associated with increased risk of non-small cell lung cancer.
    Qin H; Zhu J; Zeng Y; Du W; Shen D; Lei Z; Qian Q; Huang JA; Liu Z
    Oncotarget; 2017 Jan; 8(5):8330-8341. PubMed ID: 28039450
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
    Ther Adv Respir Dis; 2020; 14():1753466620918192. PubMed ID: 32401173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first-line, platinum-based chemotherapy.
    Zhao X; Wang X; Wu W; Gao Z; Wu J; Garfield DH; Wang H; Wang J; Qian J; Li H; Jin L; Li Q; Han B; Lu D; Bai C
    Cancer; 2012 Jul; 118(14):3587-98. PubMed ID: 22072145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients.
    Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Delgado JR; Faus-Dáder MJ; Calleja-Hernández MŸ
    Pharmacol Res; 2016 Sep; 111():877-884. PubMed ID: 27498158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAD18 polymorphisms are associated with platinum-based chemotherapy toxicity in Chinese patients with non-small cell lung cancer.
    Chu TQ; Li R; Shao MH; Ye JY; Han BH
    Acta Pharmacol Sin; 2016 Nov; 37(11):1490-1498. PubMed ID: 27665847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.